Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 944Neoplasms 713Prostatic Neoplasms 498Lung Neoplasms 402Colorectal Neoplasms 363Carcinoma, Non-Small-Cell Lung 362Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 239Brain Neoplasms 230Neoplasm Metastasis 225Multiple Myeloma 218Carcinoma, Hepatocellular 202Head and Neck Neoplasms 187Glioblastoma 183Precursor Cell Lymphoblastic Leukemia-Lymphoma 181Melanoma 177Ovarian Neoplasms 170Squamous Cell Carcinoma of Head and Neck 161Rectal Neoplasms 145Uterine Cervical Neoplasms 144Recurrence 143Hematologic Neoplasms 137Sarcoma 136Glioma 132Stomach Neoplasms 129Triple Negative Breast Neoplasms 127Carcinoma, Renal Cell 126Myelodysplastic Syndromes 114Colonic Neoplasms 113Esophageal Neoplasms 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucormycosis × 90 days × Clear all
NCT06900114 2026-03-05

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Institute of Hematology & Blood Diseases Hospital, China

Completed
60 enrolled
Other hematologic neoplasm

COVID-19, Mucormycosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡